Turn to the nation's most objective and informative daily environmental news resource to learn how the United States and key players around the world are responding to the environmental...
By Pat Rizzuto
The Environmental Protection Agency has been regulating more new chemicals since the Toxic Substances Control Act was overhauled than it did before, according to a snapshot of its work over the past 11 months.
“It’s definitely harder to get a new chemical to market,” Charles Auer, a former senior EPA chemicals official told Bloomberg BNA. Auer now is a senior regulatory and policy adviser for the Bergeson & Campbell, P.C. law firm.
Auer, who spent 32 years working on chemicals at EPA, said he had expected the new law to double or triple the number of regulations the agency would impose on new chemicals, Instead the agency’s regulation rate is vastly exceeding his expectations.
Prior to the law’s update, about 10 percent of new chemicals were regulated in some way, Auer said. A snapshot of information the EPA released May 17 suggests about 50 percent of new chemicals are being regulated since TSCA was amended, he said.
As the rate of regulation increases, chemical manufacturers are withdrawing more requests to make new chemicals than they did before the statute was revised, Dan Newton, a senior government relations manager with the Society of Chemical Manufacturers & Affiliates, told Bloomberg BNA.
Historically, companies withdrew about 5 percent of the new chemical requests they submitted to the agency, Auer said. The agency’s latest information suggests companies are withdrawing about 25 percent of their requests to make new chemicals, called premanufacture notices or PMNs, he said.
The increased rate of regulations combined with more manufacturers withdrawing their applications to make new chemicals may keep older chemicals, which traditionally raise more health and environmental concerns, on the market.
Liz Hitchcock, legislative director for the Safer Chemicals Healthy Families, thinks the EPA’s more stringent new chemical reviews are good.
One of the reasons the public was frustrated by TSCA–prior to its amendment in June 2016—is that new chemicals got very little oversight before they entered commerce, Hitchcock said.
EPA’s increased scrutiny “will build confidence in the agency’s ability to protect the public from toxic chemicals,” she said.
Auer, Hitchcock and Newton shared their insights regarding information the EPA provided Bloomberg BNA summarizing its new chemicals actions since TSCA was amended by the Lautenberg Chemical Safety Act on June 22, 2016. According to the EPA’s summary:
Between June 22, 2016, and May 9, the agency has allowed 255 new chemicals, new microbes or new uses of chemicals to enter commerce.
The EPA’s data also show that it has reduced its “backlog” of new chemicals that has built up since the Lautenberg Act’s amendments became law. The term “backlog” is shorthand for the greater than normal number of PMNs and other new chemical requests under the agency’s review since TSCA was amended.
As of May 9, 481 new chemicals or new chemical use notices were under review, the EPA said in response to emailed questions from Bloomberg BNA.
Historically, EPA has tended to have about 300 new chemicals under review at any given time, the agency said. With 481 new chemicals notices under review, that means the office has a “backlog” of 181 cases.
“EPA has revised and streamlined its process, brought in new staff to help in the reviews and is making progress in reducing the backlog of chemicals in the pipeline for review,” the agency said.
Cal Dooley, president of the American Chemistry Council, addressed the backlog issue in an April insights article he wrote for Bloomberg BNA.
At that time, the backlog of new chemicals awaiting the agency’s approval had doubled from 331 to 658 since passage of the amended law, Dooley wrote. Available information at the time had suggested the agency had approved only 33 substances since TSCA was amended, which he said was “a sharp decline for a program that has historically reviewed about 1,000 substances every year.” The chemistry council represents U.S. chemical manufacturers including 3M, Arkema, Inc., the BASF Corp., ExxonMobil Chemical Co., and LyondellBasell Industries Holdings B.V.
Auer, Hitchcock, Newton and Dimitrios Karakitsos, a partner with Holland & Knight LLP’s Washington, D.C., office, agreed the agency’s information shows it is making progress to speed its reviews of new chemicals.
“The folks at the EPA are righting the ship,” said Karakitsos, who previously served as counsel to the Republicans on the Senate Environment and Public Works Committee. In that role, he served as a principal drafter and negotiator of the amended chemicals law.
The progress to date shows EPA Administrator Scott Pruitt’s commitment to lead an agency that follows the law Congress wrote, Karakitsos said.
Democrats and Republicans supported the Lautenberg Act with the understanding from the EPA that the changes lawmakers were making to the agency’s new chemicals oversight would allow U.S. chemical manufacturers to continue innovating, he said.
“Maintaining robust innovation was a huge priority in both the House and the Senate,” Karakitsos said.
“New chemicals are generally greener, more environmentally friendly and less toxic,” he said. All sides have an interest in a predictable process that allows the products of innovation to get to market.
Auer said his experience at the EPA, which included directing the agency’s chemicals office, Office of Pollution Prevention and Toxics, taught him that chemistry is improved slowly over time.
“Most chemical developments occur through relatively small tweaks,” he said. Companies adjust some portion of a molecule, he said. That adjustment produces significant improvements in performance while reducing toxicity and saving money through means such as reduced energy use, waste generated or other environmental benefits, Auer said.
Hence, Auer and Newton said they were concerned by the agency’s increased regulation of new chemicals.
“It’s ironic there’s so much focus on restricting new chemicals,” because the problems, Newton said.
A consequence of increased regulation of new chemicals, Auer said, is that the companies that purchase chemicals to make products continue to use existing chemicals.
To contact the reporter on this story: Pat Rizzuto in Washington at email@example.com
To contact the editor responsible for this story: Paul Connolly at PConnolly@bna.com
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)